Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04031456 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients

Study acronym: PRP
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 30, 2026 to Jan 30, 2027
    • Study completion date: Jul 30, 2026 to Jul 30, 2028
    v8
  2. Re-verified, no change to tracked fieldsv7
  3. Primary completion date: Jan 30, 2024 to Jan 30, 2026
    • Study completion date: Jan 30, 2024 to Jul 30, 2026
    v6
  4. Primary and study completion dates: Jan 30, 2023 to Jan 30, 2024v5
  5. Primary completion date: Feb 25, 2021 to Jan 30, 2023v4 Show 7 more changesShow less
    • Primary endpoints revised (2)
    • Study completion date: Apr 30, 2021 to Jan 30, 2023
    • Interventions: Autologous Platelet Rich Plasma (Biological), Placebo (Other) to Autologous Platelet Rich Plasma (Biological), Placebo-Platelet Free Plasma (Biological)
    • Eligibility criteria expanded, about 66 words
    • Secondary endpoints revised (5)
    • Study description expanded, about 141 words
    • Study title expanded, about 4 words
Show 2 earlier versionsHide 2 earlier versions
  1. Eligibility criteria expanded, about 1 wordv3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve patients' hormonal profile in patients presenting with POI.
Trial Details
NCT Number NCT04031456
Lead Sponsor Genesis Athens Clinic
Collaborators: National and Kapodistrian University of Athens
Conditions
(from sponsor)		 Menopause, Premature, Menopause Related Conditions, Menopausal Syndrome, Premature Ovarian Failure, Ovarian Failure, Premature
Related terms Menopause, Premature, Primary Ovarian Insufficiency
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov